You are here

Ackman is 'profoundly' sorry for US$4b Valeant 'mistake'

BT_20170331_NAHVALEANT31_2817450.jpg
Mr Ackman said that he had learned lessons, including that "a management team with a superb long-term investment record is still capable of making significant mistakes".

New York

BILL Ackman "deeply and profoundly" apologised for his investment in Valeant Pharmaceuticals International Inc, a "huge mistake" that cost his firm US$4 billion.

In his annual letter to investors in his publicly traded fund Pershing Square Holdings Ltd, Mr Ackman in part

sentifi.com

Market voices on:

Powered by GET.comGetCom